Latest Production News

Cobre Limited has completed a $60 million capital raise to acquire majority ownership of the Sierra Atacama Copper Mine in Chile, marking its transition from explorer to producer. Meanwhile, substantial shareholder Sinomine has increased its investment in Cobre’s Botswana copper project.

Xenitra Limited has secured a $30 million AUD sales agreement for Danone products with Rockcheck Group and established its Australian subsidiary as an authorised supplier, marking a major step in its China market strategy.

Blue Star Helium has successfully raised A$10 million through an oversubscribed placement, positioning itself to accelerate production at its Galactica and Pegasus helium projects.

Aeris Resources has expanded its Golden Plateau drilling program to 14,000 metres following a series of strong high-grade gold intersections, reinforcing the deposit’s potential as a key ore source for its Cracow operation.

Variscan Mines announces the resignation of CEO Stewart Dickson and the appointment of Tom Kent as executive director, signaling a strategic shift following the San Jose Mine Restart Study.

American Tungsten & Antimony Ltd has begun a low-cost refurbishment of its Dutch Mountain tungsten mill in Utah, aiming to restart production swiftly and ease regional processing bottlenecks.

Botala Energy has commenced drilling its first commercial production well at the Serowe CBM Project in Botswana, marking a pivotal step toward large-scale gas production and regional energy supply.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.

Impact Minerals has raised A$2 million through a strategic placement to advance its High Purity Alumina project and explore new industrial minerals opportunities in Western Australia.

Beacon Minerals has completed the sale of its MacPhersons Reward project to Forrestania Resources, receiving $5 million in cash and a substantial equity stake in Forrestania. This deal positions Beacon to sharpen its focus on core assets like the Lady Ida project while maintaining exposure to MacPhersons through its new shareholding.

Shriro Holdings has introduced a new dividend policy aiming to distribute 20-30% of net profit after tax annually, balancing shareholder returns with capital needs. The Board retains discretion over payments, factoring in franking credits and strategic priorities.

Aroa Biosurgery has completed its Symphony randomised controlled trial, demonstrating improved healing rates for diabetic foot ulcers compared to standard care. The preliminary results pave the way for clinical adoption and potential US reimbursement.